Scientists Find 9 Drugs That Could Treat Child Dementia

Scientists just found a way to help children with dementia using drugs that already sit on pharmacy shelves.

Australian researchers at the South Australian Health and Medical Research Institute have identified nine existing medications that show real promise in treating Sanfilippo syndrome, the most common form of childhood dementia. Some of these drugs, like the gout medication probenecid, are already approved by the FDA for other conditions.

This matters because childhood dementia is devastating and rare, making it hard to fund new drug development. Kids with Sanfilippo syndrome rarely survive past their teenage years as toxic materials build up in their brain cells.

The research team took a clever approach. They engineered brain cells from skin donated by children with the syndrome, essentially creating the disease in a lab dish. Then they tested dozens of existing drugs to see which ones helped.

The results surprised them. Different medications targeted different parts of the problem. Some reduced toxic buildup, while others helped brain cells live longer or communicate better. A combination of these drugs could extend and improve lives for children recently diagnosed.

"By combining human brain cell models with machine learning, we can quickly identify therapies that shift diseased cells toward a healthier state," says senior author Cedric Bardy. The team used advanced imaging and artificial intelligence to analyze how each drug affected the cells.

The Ripple Effect

This discovery opens doors far beyond Sanfilippo syndrome. The same process could work for other childhood dementias caused by single-gene mutations, potentially helping hundreds of families worldwide.

Because these medications already have safety data from their approved uses, researchers can skip years of early trials. That means children could access treatments faster, buying precious time while scientists work on gene therapies that could cure the disease entirely.

The approach also gives hope to researchers studying adult dementia. As populations age, finding faster ways to test potential treatments becomes increasingly important.

For families facing childhood dementia today, this research transforms waiting into action.